First case of trastuzumab emtansine-associated hemorrhagic telangiectasias treated with propranolol.

L Peuvrel, B Bregeon,M Saint-Jean, G Quéreux, C Frénard,A Khammari, A Wdowik, B Dréno

Dermatologic Therapy(2019)

引用 0|浏览26
暂无评分
摘要
Dermatologic TherapyVolume 32, Issue 1 e12756 Therapeutic Hotline: Letter First case of trastuzumab emtansine-associated hemorrhagic telangiectasias treated with propranolol L. Peuvrel, Corresponding Author L. Peuvrel lucie.peuvrel@chu-nantes.fr orcid.org/0000-0002-4347-915X Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, France Correspondence Lucie Peuvrel, Service de dermatologie, CHU de Nantes, 1 place Alexis Ricordeau, 44000 Nantes, France. Email: lucie.peuvrel@chu-nantes.frSearch for more papers by this authorB. Bregeon, B. Bregeon Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorM. Saint-Jean, M. Saint-Jean Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorG. Quéreux, G. Quéreux Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorC. Frénard, C. Frénard Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorA. Khammari, A. Khammari Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorA. Wdowik, A. Wdowik Department of Medical Oncology, Centre Hospitalier Bretagne Atlantique, Vannes, FranceSearch for more papers by this authorB. Dréno, B. Dréno Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorSupported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments, Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatmentsSearch for more papers by this author L. Peuvrel, Corresponding Author L. Peuvrel lucie.peuvrel@chu-nantes.fr orcid.org/0000-0002-4347-915X Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, France Correspondence Lucie Peuvrel, Service de dermatologie, CHU de Nantes, 1 place Alexis Ricordeau, 44000 Nantes, France. Email: lucie.peuvrel@chu-nantes.frSearch for more papers by this authorB. Bregeon, B. Bregeon Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorM. Saint-Jean, M. Saint-Jean Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorG. Quéreux, G. Quéreux Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorC. Frénard, C. Frénard Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorA. Khammari, A. Khammari Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorA. Wdowik, A. Wdowik Department of Medical Oncology, Centre Hospitalier Bretagne Atlantique, Vannes, FranceSearch for more papers by this authorB. Dréno, B. Dréno Department of Dermatology, CHU Nantes, CIC 1413, CRCINA, Université Nantes, Nantes, FranceSearch for more papers by this authorSupported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments, Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatmentsSearch for more papers by this author First published: 04 October 2018 https://doi.org/10.1111/dth.12756Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume32, Issue1January/February 2019e12756 RelatedInformation
更多
查看译文
关键词
hemorrhagic telangiectasias,propranolol,trastuzumab,emtansine-associated
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要